Nifty
Sensex
:
:
23349.90
77155.79
-168.60 (-0.72%)
-422.59 (-0.54%)

Pharmaceuticals & Drugs - Domestic

Rating :
N/A

BSE: 500488 | NSE: ABBOTINDIA

27823.45
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  27986.90
  •  27997.15
  •  27706.05
  •  27902.35
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  8337
  •  2320.58
  •  30521.00
  •  22000.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 57,723.73
  • 45.08
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 56,618.03
  • 1.51%
  • 16.45

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 74.99%
  • 0.66%
  • 13.65%
  • FII
  • DII
  • Others
  • 0.17%
  • 8.84%
  • 1.69%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.83
  • 7.40
  • 5.98

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.66
  • 13.95
  • 6.08

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 18.03
  • 15.17
  • 14.57

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 48.06
  • 50.31
  • 49.14

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.90
  • 14.90
  • 15.27

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 28.98
  • 33.48
  • 32.74

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Net Sales
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Expenses
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBITDA
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Interest
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Depreciation
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PBT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Tax
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PAT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

News Update:


  • Abbott India signs patent license agreement with Takeda Pharmaceuticals
    20th Sep 2024, 09:21 AM

    Vonoprazan, a first-of-its kind therapy, will help make it easier for patients to comply with their treatment and manage their condition better

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.